Enhancing surgical outcomes: accurate identification and removal of prostate cancer with B7-H3-targeted NIR-II molecular imaging.

Yaqi TianHongliang ShenLingbing LiXiaohua JiaJin LiuZhenhua HuLiang WangZhenyu Zhang

Published in: European journal of nuclear medicine and molecular imaging (2024)

-800CW molecular imaging probe is capable of accurately identifying PCa lesions and guiding their removal. This approach can potentially reduce the rate of surgical margins under NIR-II fluorescence guidance.

Keyphrases

prostate cancer
photodynamic therapy
fluorescent probe
drug release
living cells
fluorescence imaging
radical prostatectomy
high resolution
cancer therapy
single molecule
quantum dots